Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion - PubMed (original) (raw)
Affiliations
- PMID: 12496369
Comparative Study
Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion
Dao Chao Huang et al. Mol Cancer Res. 2002 Nov.
Abstract
It has been previously shown that keratinocytes express a high level of 25-hydroxyvitamin D(3) (25-OHD(3)) 1alpha-hydroxylase (1alpha-hydroxylase). 1alpha-Hydroxylase catalyzes the conversion of 25-OHD(3) to 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. 1,25(OH)(2)D(3) is both antiproliferative (i.e., suppresses cell growth) and prodifferentiative (i.e., induces cell differentiation) in many cell types. We hypothesized that local production of 1,25(OH)(2)D(3) by keratinocytes may suppress their growth and induce their differentiation in an autocrine fashion. To test this hypothesis, we inactivated both 1alpha-hydroxylase alleles in a ras-transformed keratinocyte cell line, HPK1Aras, which typically produces squamous carcinoma in nude mice. To inactivate 1alpha-hydroxylase expression by HPK1Aras cells, we disrupted both alleles of the 1alpha-hydroxylase gene by homologous recombination. Lack of expression and activity of 1alpha-hydroxylase was confirmed by Northern blot analysis and detected conversion of 25-OHD(3) to 1,25(OH)(2)D(3). We then examined the effect of substrate 25-OHD(3) on parameters of growth and differentiation in the double knockout cell line as compared to wild-type HPK1Aras cells in vitro. It was found that 1alpha-hydroxylase inactivation blocked the antiproliferative and prodifferentiative effect of 25-OHD(3). These in vitro effects were further analyzed in vivo by injecting knockout or control cells subcutaneously in severely compromised immunodeficient mice. Tumor growth was accelerated and differentiation was inhibited in mice given injections of knockout cells as compared to control cells in the presence of substrate 25-OHD(3). Our results demonstrate, for the first time, that 1alpha-hydroxylase expression by keratinocytes plays an important role in autocrine growth and differentiation of these cells, and suggest that expression of this enzyme may modulate tumor growth in squamous carcinomas.
Similar articles
- Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. Masuda S, et al. Endocrinology. 2005 Feb;146(2):825-34. doi: 10.1210/en.2004-1116. Epub 2004 Oct 21. Endocrinology. 2005. PMID: 15498883 - Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS. Bareis P, et al. Exp Cell Res. 2002 Jun 10;276(2):320-7. doi: 10.1006/excr.2002.5528. Exp Cell Res. 2002. PMID: 12027461 - Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer.
Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF. Chen TC, et al. J Cell Biochem. 2003 Feb 1;88(2):315-22. doi: 10.1002/jcb.10342. J Cell Biochem. 2003. PMID: 12520532 Review. - Vitamin D and placental-decidual function.
Evans KN, Bulmer JN, Kilby MD, Hewison M. Evans KN, et al. J Soc Gynecol Investig. 2004 Jul;11(5):263-71. doi: 10.1016/j.jsgi.2004.02.002. J Soc Gynecol Investig. 2004. PMID: 15219879 Review.
Cited by
- 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G. Segersten U, et al. Breast Cancer Res. 2005;7(6):R980-6. doi: 10.1186/bcr1332. Epub 2005 Oct 6. Breast Cancer Res. 2005. PMID: 16280049 Free PMC article. - Protective links between vitamin D, inflammatory bowel disease and colon cancer.
Meeker S, Seamons A, Maggio-Price L, Paik J. Meeker S, et al. World J Gastroenterol. 2016 Jan 21;22(3):933-48. doi: 10.3748/wjg.v22.i3.933. World J Gastroenterol. 2016. PMID: 26811638 Free PMC article. Review. - Vitamin D and human health: lessons from vitamin D receptor null mice.
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Bouillon R, et al. Endocr Rev. 2008 Oct;29(6):726-76. doi: 10.1210/er.2008-0004. Epub 2008 Aug 11. Endocr Rev. 2008. PMID: 18694980 Free PMC article. Review. - Characterization of the autocrine/paracrine function of vitamin D in human gingival fibroblasts and periodontal ligament cells.
Liu K, Meng H, Hou J. Liu K, et al. PLoS One. 2012;7(6):e39878. doi: 10.1371/journal.pone.0039878. Epub 2012 Jun 25. PLoS One. 2012. PMID: 22761920 Free PMC article. - Vitamin D and cancer: a review of molecular mechanisms.
Fleet JC, DeSmet M, Johnson R, Li Y. Fleet JC, et al. Biochem J. 2012 Jan 1;441(1):61-76. doi: 10.1042/BJ20110744. Biochem J. 2012. PMID: 22168439 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases